FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Henning Mouridsen

Research Profile

Disorders

Breast Neoplasms

Geographic Areas

Denmark

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Postmenopause

Co-author Network

Publications

TOP 3
Marianne Ewertz; John Forbes; Richard D Gelber; Aron Goldhirsch; Kathryn P Gray; István Láng; Hervé Bonnefoi; Alan S Coates; Marco Colleoni; Bent Ejlertsen; Robert Paridaens; Karen N Price; Manuela Rabaglio; Meredith M Regan; Ian E Smith; Beat Thürlimann; Henning T Mouridsen
Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
Henning T Mouridsen; Susanne Møller; Peer Christiansen
[Danish Breast Cancer Cooperative Group].
Kirsten Vang Nielsen; Sven Müller; Eva Balslev; Bent Ejlertsen; Maj-Britt Jensen; Ann Knoop; Susanne Møller; Henning T Mouridsen
Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Henning Mouridsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Marianne Ewertz; John Forbes; Richard D Gelber; Aron Goldhirsch; Kathryn P Gray; István Láng; Hervé Bonnefoi; Alan S Coates; Marco Colleoni; Bent Ejlertsen; Robert Paridaens; Karen N Price; Manuela Rabaglio; Meredith M Regan; Ian E Smith; Beat Thürlimann; Henning T Mouridsen
Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(32):3967-75.
2012: Henning T Mouridsen; Susanne Møller; Peer Christiansen
[Danish Breast Cancer Cooperative Group].
Ugeskrift for laeger 2012;174(42):2532.
2012: Kirsten Vang Nielsen; Sven Müller; Eva Balslev; Bent Ejlertsen; Maj-Britt Jensen; Ann Knoop; Susanne Møller; Henning T Mouridsen
Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status.
Molecular oncology 2012;6(1):88-97.
2011: Peer Christiansen; Bent Ejlertsen; Marianne Ewertz; Maj-Britt Jensen; Niels Kroman; Anne-Vibeke Laenkholm; Susanne Møller; Henning T Mouridsen; Birgitte Offersen; Birgitte B Rasmussen; Dorte B Toftdahl; Karsten Bjerre
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Journal of the National Cancer Institute 2011;103(18):1363-72.
2011: Kirsten Vang Nielsen; Bent Ejlertsen; Sven Müller; Susanne Møller; Birgitte B Rasmussen; Eva Balslev; Anne-Vibeke Laenkholm; Peer Christiansen; Henning T Mouridsen
Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.
Breast cancer research and treatment 2011;127(2):345-55.
2010: Henning T Mouridsen; Per Lønning; Matthias W Beckmann; Kimberly Blackwell; Julie Doughty; Joseph GLIGOROV; Antonio Llombart-Cussac; Andre Robidoux; Beat Thürlimann; Michael Gnant
Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.
Expert review of anticancer therapy 2010;10(11):1825-36.
2010: Bent Ejlertsen; Henning T Mouridsen; Maj-Britt Jensen; Jørn Andersen; Michael Andersson; Claus Kamby; Ann S Knoop
Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer.
Cancer 2010;116(9):2081-9.
2010: Bent Ejlertsen; Maj-Britt Jensen; Kirsten Vang Nielsen; Eva Balslev; Birgitte B Rasmussen; Gro L Willemoe; Pernille B Hertel; Ann S Knoop; Henning T Mouridsen; Nils Brünner
HER2, TOP2A, and TIMP-1 and responsiveness to adjuvant anthracycline-containing chemotherapy in high-risk breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(6):984-90.
2010: Henning T Mouridsen
The differences in outcome between ATAC and BIG 1-98 suggest efficacy differences between these two nonsteroidal AIs.
Cancer investigation 2010;28 Suppl 1():1-3.
2009: Bent Ejlertsen; Maj-Britt Jensen; Fritz Rank; Birgitte B Rasmussen; Peer Christiansen; Niels Kroman; Marianne E Kvistgaard; Marie Overgaard; Dorte B Toftdahl; Henning T Mouridsen
Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer.
Journal of the National Cancer Institute 2009;101(10):729-35.
2009: Anne E Lykkesfeldt; Katrine L Henriksen; Birgitte B Rasmussen; Hironobu Sasano; Dean B Evans; Susanne Møller; Bent Ejlertsen; Henning T Mouridsen
In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.
BMC cancer 2009;9():185.
2009: Katrine L Henriksen; Birgitte Bruun Rasmussen; Anne E Lykkesfeldt; Susanne Møller; Bent Ejlertsen; Henning T Mouridsen
An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Acta oncologica (Stockholm, Sweden) 2009;48(4):522-31.
2008: Siri Beier Jensen; Henning T Mouridsen; Olav J Bergmann; Jesper Reibel; Nils Brünner; Birgitte Nauntofte
Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2008;106(2):217-26.
2008: Siri Beier Jensen; Henning T Mouridsen; Jesper Reibel; Nils Brünner; Birgitte Nauntofte
Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
Oral oncology 2008;44(2):162-73.
2008: Bent Kristensen; Bent Ejlertsen; Henning T Mouridsen; Maj-Britt Jensen; Jørn Andersen; Brita Bjerregaard; Søren Cold; Per Edlund; Marianne Ewertz; Claus Kamby; Henrik Lindman; Bo Nordenskjöld; Jonas Bergh
Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.
Acta oncologica (Stockholm, Sweden) 2008;47(4):740-6.
2008: Kirsten Vang Nielsen; Bent Ejlertsen; Susanne Møller; Jan Trøst Jørgensen; Ann Knoop; Helle Knudsen; Henning T Mouridsen
The value of TOP2A gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D.
Acta oncologica (Stockholm, Sweden) 2008;47(4):725-34.
2008: Bent Ejlertsen; Maj-Britt Jensen; Henning T Mouridsen; Jørn Andersen; Søren Cold; Erik Jakobsen; Claus Kamby; Peter G Sørensen; Marianne Ewertz
DBCG trial 89B comparing adjuvant CMF and ovarian ablation: similar outcome for eligible but non-enrolled and randomized breast cancer patients.
Acta oncologica (Stockholm, Sweden) 2008;47(4):709-17.
2008: Mogens Blichert-Toft; Maja Nielsen; Maria Düring; Susanne Møller; Fritz Rank; Marie Overgaard; Henning T Mouridsen
Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol.
Acta oncologica (Stockholm, Sweden) 2008;47(4):672-81.
2008: Bent Ejlertsen; Henning T Mouridsen; Maj-Britt Jensen
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Acta oncologica (Stockholm, Sweden) 2008;47(4):662-71.
2008: Helge Johansen; Sigvard Kaae; Maj-Britt Jensen; Henning T Mouridsen
Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised study.
Acta oncologica (Stockholm, Sweden) 2008;47(4):633-8.
2008: Henning T Mouridsen; Karsten D Bjerre; Peer Christiansen; Maj-Britt Jensen; Susanne Møller
Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry.
Acta oncologica (Stockholm, Sweden) 2008;47(4):525-36.
2008: Susanne Møller; Maj-Britt Jensen; Bent Ejlertsen; Karsten D Bjerre; Martin Larsen; Hanne B Hansen; Peer Christiansen; Henning T Mouridsen
The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise.
Acta oncologica (Stockholm, Sweden) 2008;47(4):506-24.
2008: Mogens Blichert-Toft; Peer Christiansen; Henning T Mouridsen
Danish Breast Cancer Cooperative Group--DBCG: History, organization, and status of scientific achievements at 30-year anniversary.
Acta oncologica (Stockholm, Sweden) 2008;47(4):497-505.
2007: Mogens Groenvold; Morten Aa Petersen; Ellen Idler; Jakob B Bjorner; Peter M Fayers; Henning T Mouridsen
Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients.
Breast cancer research and treatment 2007;105(2):209-19.
2007: Henning T Mouridsen; Jørn Andersen
[Adjuvant treatment of breast cancer. Endocrine therapy].
Ugeskrift for laeger 2007;169(37):3072-6.
2007: Mogens Groenvold; Peter M Fayers; Morten Aa Petersen; Mirjam A G Sprangers; Neil Aaronson; Henning T Mouridsen
Breast cancer patients on adjuvant chemotherapy report a wide range of problems not identified by health-care staff.
Breast cancer research and treatment 2007;103(2):185-95.
2007: Katrine L Henriksen; Birgitte Bruun Rasmussen; Anne E Lykkesfeldt; Susann Møller; Bent Ejlertsen; Henning T Mouridsen
Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.
Journal of clinical pathology 2007;60(4):397-404.
2007: Bent Ejlertsen; Henning T Mouridsen; Maj-Britt Jensen; Jørn Andersen; Søren Cold; Per Edlund; Marianne Ewertz; Brita B Jensen; Claus Kamby; Bo Nordenskjold; Jonas Bergh
Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer.
European journal of cancer (Oxford, England : 1990) 2007;43(5):877-84.
2007: Henning T Mouridsen; Seppo Langer; J Buter; H Eidtmann; G Rosti; Maike de Wit; P Knoblauch; A Rasmussen; K Dahlstrøm; Peter B Jensen; G Giaccone
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):546-50.
2007: Henning T Mouridsen
Letrozole in advanced breast cancer: the PO25 trial.
Breast cancer research and treatment 2007;105 Suppl 1():19-29.
2006: Anne-Sofie Schrohl; Marion E Meijer-Van Gelder; Mads N Holten-Andersen; Ib Jarle Christensen; Maxime P Look; Henning T Mouridsen; Nils Brünner; John A Foekens
Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7054-8.
2006: Bent Ejlertsen; Henning T Mouridsen; Maj-Britt Jensen; Nils-Olof Bengtsson; Jonas Bergh; Søren Cold; Per Edlund; Marianne Ewertz; Peter W de Graaf; Claus Kamby; Dorte Lisbet Nielsen
Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):4956-62.
2006: Lise H Christensen; Gerda Engholm; R Cortes; Jeanette Ceberg; Ulla Brix Tange; Michael Andersson; Anna Bladström; Henning T Mouridsen; Torgil R Möller; Hans Storm
Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden.
European journal of cancer (Oxford, England : 1990) 2006;42(16):2773-80.
2006: Henning T Mouridsen
Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.
Current medical research and opinion 2006;22(8):1609-21.
2006: Mogens Groenvold; Peter M Fayers; Morten Aa Petersen; Henning T Mouridsen
Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
Breast cancer research and treatment 2006;98(3):275-84.
2006: Ilse Vejborg; Niels Kroman; Peer Christiansen; Henning T Mouridsen; Henrik Flyger
[Mammography screening--ideology contra science].
Ugeskrift for laeger 2006;168(23):2263; author reply 2263-5.
2005: Henning T Mouridsen; Nicholas J Robert
The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
European journal of cancer (Oxford, England : 1990) 2005;41(12):1678-89.
2005: Henning T Mouridsen; Ajay S Bhatnagar
Letrozole in the treatment of breast cancer.
Expert opinion on pharmacotherapy 2005;6(8):1389-99.
2005: Ilse Vejborg; Niels Kroman; Peer Christiansen; Henning T Mouridsen; Henrik Flyger
[Mammography screening--one more time].
Ugeskrift for laeger 2005;167(16):1767-8.
2005: Henning T Mouridsen; Nicholas J Robert
Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer.
MedGenMed : Medscape general medicine 2005;7(3):20.
2004: Henning T Mouridsen
Aromatase inhibitors in advanced breast cancer.
Seminars in oncology 2004;31(6 Suppl 12):3-8.
2004: Henning T Mouridsen
Exemestane following tamoxifen in postmenopausal women with primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3833-4.
2004: Bent Ejlertsen; Henning T Mouridsen; Sven T Langkjer; Jørn Andersen; Johanna Sjöström; Mogens Kjaer
Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2313-20.
2004: Lise H Christensen; Gerda Engholm; Jeanette Ceberg; S Hein; Roland Perfekt; Ulla Brix Tange; Michael Andersson; Henning T Mouridsen; Torgil R Möller; Hans H Storm
Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?--a population-based study.
European journal of cancer (Oxford, England : 1990) 2004;40(8):1233-43.
2004: Henning T Mouridsen; Nils Brünner
Clinical infrastructures to support proteomic studies of tissue and fluids in breast cancer.
Molecular & cellular proteomics : MCP 2004;3(4):302-10.
2004: Niels Kroman; Helle Holtveg; Jan Wohlfahrt; Maj-Britt Jensen; Henning T Mouridsen; Mogens Blichert-Toft; Mads Melbye
Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma.
Cancer 2004;100(4):688-93.
2003: Niels Kroman; Henning T Mouridsen
Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer.
Breast (Edinburgh, Scotland) 2003;12(6):516-21.
2003: Henning T Mouridsen; Carsten Rose; Angela Brodie; Ian E Smith
Challenges in the endocrine management of breast cancer.
Breast (Edinburgh, Scotland) 2003;12 Suppl 2():S2-19.
2003: Angela Brodie; Henning T Mouridsen
Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy.
American journal of clinical oncology 2003;26(4):S17-26.
2003: Niels Kroman; Jan Wohlfahrt; Henning T Mouridsen; Mads Melbye
Influence of tumor location on breast cancer prognosis.
International journal of cancer. Journal international du cancer 2003;105(4):542-5.
2003: Agnes N Pedersen; Henning T Mouridsen; D Y Tenney; Nils Brünner
Immunoassays of urokinase (uPA) and its type-1 inhibitor (PAI-1) in detergent extracts of breast cancer tissue.
European journal of cancer (Oxford, England : 1990) 2003;39(7):899-908.
2003: Bent Ejlertsen; I Højris; S Hansen; K Møholt; Bent Kristensen; Henning T Mouridsen; Jørn Andersen; C Rose; M Kjaer
Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group.
Breast (Edinburgh, Scotland) 2003;12(1):42-50.
2003: Karen Hjerl; Elisabeth W Andersen; Niels Keiding; Henning T Mouridsen; Preben B Mortensen; Torben Jørgensen
Depression as a prognostic factor for breast cancer mortality.
Psychosomatics 2003;44(1):24-30.
2002: A T van Oosterom; Henning T Mouridsen; Ole Steen Nielsen; Per Dombernowsky; K Krzemieniecki; I Judson; L Svancarova; D Spooner; C Hermans; Martine Van Glabbeke; J Verweij
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
European journal of cancer (Oxford, England : 1990) 2002;38(18):2397-406.
2002: Niels Kroman; Mads Melbye; Henning T Mouridsen
Prognostic influence of age at diagnosis in premenopausal breast cancer patients.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2002;91(3):305-8.
2002: Ulla Brix Tange; Maj-Britt Jensen; Ilse Vejborg; Fritz Rank; Mogens Blichert-Toft; Henning T Mouridsen; Elsebeth Lynge
Clinical impact of introduction of mammography screening in a non-screening country with special reference to the Copenhagen service mammography screening programme.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2002;91(3):293-303.
2001: Jon Thor Bergthorsson; Bent Ejlertsen; Jørgen H Olsen; Ake Borg; Kirsten Vang Nielsen; Rosa B Barkardottir; S Klausen; Henning T Mouridsen; K Winther; Kirsten Fenger; A Niebuhr; T L Harboe; Erik Niebuhr
BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age.
Journal of medical genetics 2001;38(6):361-8.
2001: Klaus Rostgaard; Henning T Mouridsen; Michael Vaeth; Henrik Uffe Holst; Knud P Olesen; Elsebeth Lynge
A modified Nottingham prognostic index for breast cancer patients diagnosed in Denmark 1978-1994.
Acta oncologica (Stockholm, Sweden) 2001;40(7):838-43.
2000: Agnes N Pedersen; Ib Jarle Christensen; Ross W Stephens; P Briand; Henning T Mouridsen; Keld Danø; Nils Brünner
The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival.
Cancer research 2000;60(24):6927-34.
2000: Henning T Mouridsen
Rationale and use of epirubicin-based therapy in the adjuvant setting.
Clinical breast cancer 2000;1 Suppl 1():S34-40.
2000: Klaus Rostgaard; Henrik Uffe Holst; Henning T Mouridsen; Elsebeth Lynge
Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark.
Cancer causes & control : CCC 2000;11(7):669-74.
2000: C Rose; Claus Kamby; Henning T Mouridsen; Michael Andersson; Lars Bastholt; K A Møller; J Andersen; P Munkholm; Per Dombernowsky; Ib Jarle Christensen
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
Breast cancer research and treatment 2000;61(2):103-10.
2000: Niels Kroman; Maj-Britt Jensen; Jan Wohlfahrt; Henning T Mouridsen; Per Kragh Andersen; Mads Melbye
Factors influencing the effect of age on prognosis in breast cancer: population based study.
BMJ (Clinical research ed.) 2000;320(7233):474-8.
2000: Niels Kroman; S M Thorpe; Jan Wohlfahrt; KW Andersen; Henning T Mouridsen
Variations in prognostic factors in primary breast cancer throughout the menstrual cycle.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2000;26(1):11-6.
2000: Christen Kirk Axelsson; Fritz Rank; Mogens Blichert-Toft; Henning T Mouridsen; Maj-Britt Jensen
Impact of axillary dissection on staging and regional control in breast tumors < or = 10 mm--the DBCG experience. The Danish Breast Cancer Cooperative Group (DBCG), Rigshisoutalet, Copenhagen, Denmark.
Acta oncologica (Stockholm, Sweden) 2000;39(3):283-9.
1999: Bent Kristensen; Bent Ejlertsen; Mogens Groenvold; S Hein; H Loft; Henning T Mouridsen
Oral clodronate in breast cancer patients with bone metastases: a randomized study.
Journal of internal medicine 1999;246(1):67-74.
1999: Mogens Groenvold; P M Fayers; M A Sprangers; Jakob B Bjorner; Marianne C Klee; N K Aaronson; Per Bech; Henning T Mouridsen
Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison?
Journal of clinical epidemiology 1999;52(6):523-30.
1999: Marie Overgaard; Maj-Britt Jensen; Jens Overgaard; P S Hansen; C Rose; Michael Andersson; Claus Kamby; M Kjaer; Carl C Gadeberg; B B Rasmussen; M Blichert-Toft; Henning T Mouridsen
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
Lancet 1999;353(9165):1641-8.
1999: Michael Andersson; E L Madsen; Marie Overgaard; C Rose; Per Dombernowsky; Henning T Mouridsen
Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG).
European journal of cancer (Oxford, England : 1990) 1999;35(1):39-46.
1998: Niels Kroman; Jan Wohlfahrt; KW Andersen; Henning T Mouridsen; Tine Westergaard; Mads Melbye
Parity, age at first childbirth and the prognosis of primary breast cancer.
British journal of cancer 1998;78(11):1529-33.
1998: Bent Kristensen; Bent Ejlertsen; Henning T Mouridsen; H Loft
Survival in breast cancer patients after the first episode of hypercalcaemia.
Journal of internal medicine 1998;244(3):189-98.
1997: Niels Kroman; Jan Wohlfahrt; KW Andersen; Henning T Mouridsen; Tine Westergaard; Mads Melbye
Time since childbirth and prognosis in primary breast cancer: population based study.
BMJ (Clinical research ed.) 1997;315(7112):851-5.
1997: Marie Overgaard; P S Hansen; Jens Overgaard; C Rose; Michael Andersson; F Bach; M Kjaer; Carl C Gadeberg; Henning T Mouridsen; Maj-Britt Jensen; K Zedeler
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
The New England journal of medicine 1997;337(14):949-55.
1997: Kirsten Vang Nielsen; Erik Niebuhr; Bent Ejlertsen; Søren Holstebroe; MW Madsen; Per Briand; Henning T Mouridsen; Lars Bolund
Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in situ hybridization.
Genes, chromosomes & cancer 1997;20(1):30-7.
1997: Niels Kroman; Maj-Britt Jensen; Mads Melbye; Jan Wohlfahrt; Henning T Mouridsen
Should women be advised against pregnancy after breast-cancer treatment?
Lancet 1997;350(9074):319-22.
1997: J Grøndahl-Hansen; Ib Jarle Christensen; P Briand; Helle Pappot; Henning T Mouridsen; Mogens Blichert-Toft; Keld Danø; Nils Brünner
Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):233-9.
1997: P S Hansen; E Andersen; KW Andersen; Henning T Mouridsen
Quality control of end results in a Danish adjuvant breast cancer multi-center study.
Acta oncologica (Stockholm, Sweden) 1997;36(7):711-4.